$2.47
-3.5%American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
Weak cash conversion. Significant portion of earnings not converting to cashโreview working capital trends and capital intensity.
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
AVD โข NYSE
| American Vanguard Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
-126.3M | -126.3M | 7.5M | 27.4M | 18.6M | 15.2M | 13.6M | 24.1M | 20.4M | 13M | 6.3M | 4.1M | 33.9M | 36.8M | 22.1M | 11M | -5.8M | 20M | 18.7M | 15.4M | |
22.5M | 22.3M | 21.8M | 22.1M | 26.2M | 19.9M | 18.6M | 18.9M | 17M | 16.3M | 16.5M | 16.3M | 14.8M | 13.5M | 13.5M | 14.4M | 13.5M | 11.6M | 10.1M | 6.7M | |
1.5M | -95K | -10.2M | -6.7M | -3.9M | -1.1M | 2.6M | -561K | 398K | -151K | 27K | 2.6M | 2.5M | -886K | 4.7M | 5.3M | -778K | 3.7M | 990K | 139K | |
4.4M | 4.4M | 6.1M | 5.7M | 6.9M | 6.6M | 7.2M | 5.8M | 4.7M | 3.2M | 3.9M | 4.2M | 3.8M | 3M | 2M | 1.1M | 1.2M | 0.0 | 0.0 | 0.0 | |
122.1M | 55.6M | 4M | 6.7M | 2.2M | 105K | 1.4M | 5.6M | 5.4M | 5.5M | 6M | 5.9M | 5.3M | 3.1M | 3.4M | 1.1M | 1.2M | 822K | 791K | 984K | |
(3.9M) | (8.8M) | (9.4M) | (20M) | (5.8M) | (3.9M) | (9.3M) | -8.4M | (17.8M) | (4.9M) | (3.7M) | (8.2M) | (25.3M) | (18M) | (6.4M) | (2.2M) | (3.4M) | (6.8M) | (0.0) | (0.0) | |
-20.2M | 48M | -87.9M | 1.9M | 36.4M | 49.6M | -34M | -42.5M | 11.2M | 8.6M | 45.8M | -67.1M | -66.7M | -15.1M | -6.4M | 1.4M | 23.8M | -33.3M | 24.9M | -53.1M | |
3.9M | 3.9M | -58.7M | 57.1M | 86.4M | 90.3M | 9.4M | 11.3M | 59M | 46.4M | 78.6M | -34.1M | -6.2M | 40.4M | 39.3M | 33.2M | 32M | 3.1M | 55.5M | -29.8M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-7.3M | -7.7M | -12.1M | -14.6M | -10M | -15.3M | -13M | -27.7M | -88.6M | -10.9M | -43.6M | -7.2M | -15.3M | -21.1M | -6.6M | -40.7M | -4.3M | -23.3M | -13.9M | -46.8M | |
(0.0) | (0.0) | -5.2M | (0.0) | -10M | -19.3M | -41.9M | -19.7M | -81.9M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -950K | -3.3M | -125K | -500K | -3.7M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 88.6M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
656K | 1.1M | 242K | 84K | 0.0 | -1.2M | -3.9M | 0.0 | -6.7M | -3.5M | -36.8M | -500K | -3.7M | -3.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -276K | |
-6.6M | -6.6M | -17M | -14.5M | -20M | -35.8M | -54.8M | -27.7M | -89.5M | -14.1M | -43.7M | -7.7M | -18.9M | -21.1M | -6.6M | -40.7M | -4.3M | -23.3M | -13.9M | -47.1M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
424K | -1.4M | -17.5M | -36.1M | -7.5M | -2.7M | -3M | -5.6M | 0.0 | 0.0 | 317K | -1.5M | -1.9M | 0.0 | 0.0 | 768K | 1.5M | 1.1M | 969K | 24.1M | |
23.3M | 8.4M | 86.6M | -1M | -55.6M | -41.6M | 51.9M | 19M | 37M | -27.6M | -30.5M | 47.9M | -604K | -8.5M | 4.3M | 8.2M | -28.4M | 20.4M | -39.6M | 55.4M | |
-2.5M | -2.5M | -3.4M | -2.8M | -2.4M | -1.2M | -2.3M | -2.2M | -1.6M | -578K | -1.1M | -5.7M | -4.8M | -6.1M | -2.2M | -819K | -1.6M | -2.1M | -1.8M | -2.2M | |
-1.4M | -1.4M | -17.5M | -36.1M | -7.5M | -2.7M | -3.7M | -7.3M | -713K | (0.0) | (0.0) | -1.5M | -1.9M | (0.0) | (20.1M) | (0.0) | (0.0) | -408K | (0.0) | (0.0) | |
-16.7M | 51K | 1M | 1.6M | -386K | 1.1M | 546K | -73K | -1.5M | -367K | -1.5M | 509K | 219K | -1.8M | 179K | 0.0 | 0.0 | 133K | 0.0 | 0.0 | |
4.5M | 4.5M | 66.7M | -38.3M | -65.9M | -44.4M | 46.4M | 11.1M | 33.9M | -28.5M | -32.9M | 41.2M | -7.1M | -16.4M | 2.3M | 8.1M | -28.6M | 19.4M | -40.5M | 77.3M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-742K | -742K | 116K | -332K | -86K | -747K | -559K | 49K | 44K | -1.4M | -1.4M | -1.2M | 488K | 497K | -1.1M | 138K | 110K | -1.1M | 212K | 50K | |
1.1M | 1.1M | -8.9M | 4M | 362K | 9.3M | 413K | -5.2M | 3.5M | 2.3M | 639K | -1.8M | -31.8M | 3.4M | 33.9M | 775K | -846K | -2M | 1.4M | 502K | |
11.4M | 11.4M | 20.3M | 16.3M | 15.9M | 6.6M | 6.2M | 11.3M | 7.9M | 5.5M | 4.9M | 6.7M | 38.5M | 35.1M | 1.2M | 383K | 1.2M | 3.2M | 1.8M | 1.3M | |
12.5M | 12.5M | 11.4M | 20.3M | 16.3M | 15.9M | 6.6M | 6.2M | 11.3M | 7.9M | 5.5M | 4.9M | 6.7M | 38.5M | 35.1M | 1.2M | 383K | 1.2M | 3.2M | 1.8M | |
-3.4M | -3.8M | -70.8M | 42.6M | 76.3M | 75.1M | -3.6M | -16.4M | -29.6M | 35.6M | 35M | -41.3M | -21.5M | 19.3M | 32.7M | -7.5M | 27.6M | -20.2M | 41.6M | -76.6M |
AVD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 15, 2026 | April 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 19, 2026 | March 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 16, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 10, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 10, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 19, 2025 | August 18, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 01, 2025 | July 31, 2025 | 2025 |
Continue your AVD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.